Increase/Decrease in Cash: The total change in cash for the company over the given period.
MacroGenics, Inc. (MGNX) had Increase/Decrease in Cash of $56.69M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$32.83M |
|
$19.52M |
|
-- |
|
$32.83M |
|
$46.68M |
|
$-13.85M |
|
$-55.79M |
|
$-69.64M |
|
$-69.64M |
|
$-69.64M |
|
$-69.64M |
|
$19.52M |
|
$-69.64M |
|
$-13.85M |
|
$-13.59M |
|
63.59M |
|
63.59M |
|
$0.31 |
|
$0.31 |
|
| Balance Sheet Financials | |
$321.69M |
|
$2.39M |
|
$23.72M |
|
$345.41M |
|
$108.81M |
|
-- |
|
$193.72M |
|
$302.54M |
|
$42.87M |
|
$42.87M |
|
$42.87M |
|
63.65M |
|
| Cash Flow Statement Financials | |
$-76.56M |
|
$73.28M |
|
$59.97M |
|
$57.22M |
|
$113.91M |
|
|
Increase/Decrease in Cash |
$56.69M |
$4.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.96 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-42.19% |
|
-42.19% |
|
-- |
|
-212.12% |
|
59.44% |
|
$-77.71M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
0.23 |
|
395.21 |
|
-162.44% |
|
-162.44% |
|
-20.16% |
|
-162.44% |
|
$0.67 |
|
$-1.22 |
|
$-1.20 |
|